AUL
TMO icon

AlphaGrep UK Ltd’s Thermo Fisher Scientific TMO Stock Holding History

AlphaGrep UK Ltd’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$556K Buy
+1,132
New +$614K 0.16% 199

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AlphaGrep UK Ltd's TMO Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 1,132 shares worth $556K. The stake represents 0.16% of the portfolio and ranks #199 among its holdings.

2,598 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AlphaGrep UK Ltd held 1,132 shares of Thermo Fisher Scientific worth $556K as of Q1 2026.
  • Thermo Fisher Scientific was a new AlphaGrep UK Ltd position in Q1 2026.
  • Thermo Fisher Scientific made up 0.16% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #199 holding.
  • 2,598 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.